ChronoScale Corporation Common Stock (NASDAQ:CHRN) Stock Price Up 13.2% – Here’s What Happened

ChronoScale Corporation Common Stock (NASDAQ:CHRN)’s stock price rose 13.2% during mid-day trading on Wednesday. The company traded as high as $12.49 and last traded at $12.21. 160,588 shares were traded during mid-day trading, a decline of 27% from the average daily volume of 220,943 shares. The stock had previously closed at $10.79.

Analyst Ratings Changes

Several research firms recently commented on CHRN. Weiss Ratings cut ChronoScale Corporation Common Stock from a “sell (d)” rating to a “sell (d-)” rating in a research note on Friday, October 23rd. Northland Securities began coverage on ChronoScale Corporation Common Stock in a research report on Friday, September 18th. They issued an “outperform” rating and a $32.00 price target on the stock. Finally, Compass Point began coverage on ChronoScale Corporation Common Stock in a research report on Friday, October 16th. They issued a “buy” rating and a $25.00 price target on the stock. Two analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, ChronoScale Corporation Common Stock currently has a consensus rating of “Hold” and a consensus target price of $21.00.

ChronoScale Corporation Common Stock Stock Up 9.1%

The company has a current ratio of 0.30, a quick ratio of 0.30 and a debt-to-equity ratio of 0.02. The company has a market cap of $1.71 billion, a price-to-earnings ratio of -2.72 and a beta of 1.12. The firm’s fifty day simple moving average is $17.33 and its 200 day simple moving average is $16.09.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last announced its quarterly earnings data on Wednesday, October 14th. The company reported ($0.29) earnings per share for the quarter. The firm had revenue of $41.48 million during the quarter. ChronoScale Corporation Common Stock had a negative net margin of 135.66% and a negative return on equity of 66.16%. Sell-side analysts predict that ChronoScale Corporation Common Stock will post -0.49 earnings per share for the current year.

ChronoScale Corporation Common Stock Company Profile

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.